Shumeng Zhang

Cell block samples from malignant pleural effusion might be valid alternative samples for anaplastic lymphoma kinase detection in patients with advanced non‐small‐cell lung cancer

J. Zhao, Caicun Zhou, Jianying Zhou, 2015, Histopathology.

Gene status and clinicopathologic characteristics of lung adenocarcinomas with mediastinal lymph node metastasis

J. Zhao, Jianying Zhou, Shumeng Zhang, 2016, Oncotarget.

The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model

L. Lv, Qiaomai Xu, B. Zheng, 2022, Applied Microbiology and Biotechnology.

Palbociclib, a selective CDK4/6 inhibitor, enhances the effect of selumetinib in RAS-driven non-small cell lung cancer.

Jianya Zhou, Guohua Lu, Shumeng Zhang, 2017, Cancer letters.

MicroRNA-206 inhibits the viability and migration of human lung adenocarcinoma cells partly by targeting MET.

Jian-Ying Zhou, Jian-ya Zhou, Yake Yao, 2016, Oncology letters.

Immunomodulatory effects of CDK4/6 inhibitors.

Qiaomai Xu, Wenjia Sun, Jianya Zhou, 2023, Biochimica et biophysica acta. Reviews on cancer.

Efficacy and surgical safety of sequential surgical resection after pembrolizumab plus chemotherapy for initial unresectable stage IIIB non-small cell lung cancer.

M. Wang, Hao Chen, Kexin Ruan, 2023, Lung cancer.

Epigenetic therapy: Research progress of decitabine in the treatment of solid tumors.

Jianya Zhou, Shumeng Zhang, Jing Zheng, 2023, Biochimica et biophysica acta. Reviews on cancer.

CD57-positive CD8 + T cells define the response to anti-programmed cell death protein-1 immunotherapy in patients with advanced non-small cell lung cancer

Wenjia Sun, Jianya Zhou, Shumeng Zhang, 2024, NPJ precision oncology.